Ernexa Therapeutics Inc. Shares, Issued
Ernexa Therapeutics Inc. (ERNA) had Shares, Issued of 203 shares as of 2026-05-04, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Equity
us-gaap:SharesIssued · last filed 2026-08-06
- 2026-05-04: Shares, Issued 203.00 shares.
- 2025-06-02: Shares, Issued 153.00 shares; Shares, Issued as first filed 153.00K shares.
| Period end | Shares, Issued | Shares, Issued as first filed |
|---|---|---|
| 2026-05-04 | 203.00 shares 10-Q · filed 2026-08-06 | |
| 2025-06-02 | 153.00 shares 10-K · filed 2026-03-13 | 153.00K shares 10-Q · filed 2025-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |